Cosmetic Surgeries Doubled in Past 12 Years

  Relationship Between Market Trends And Cosmetic Case Volume Analyzed in Study Despite the economic downturn of the early 2000s, cosmetic surgery grew from 2000 to 2012, in large part due to an increasing volume of minimally invasive procedures, including injectables. This growth, though not without appreciable deceleration at the low point of the recession,…

Read More

Hidradenitis Suppurativa: Number of Diagnosed Patients, Demographic Characteristics, and Treatment Patterns in the United States

  Abstract Recent regional and insurance database studies indicate that diagnoses of hidradenitis suppurativa (HS) are rare, with fewer than 200,000 affected patients in the United States. These findings are at odds with the generally accepted prevalence of approximately 1%. To estimate the number of patients diagnosed with HS, including patients enrolled in public health…

Read More

TNF Blocker Promising for Hidradenitis Suppurativa Treatment

  The first randomized, controlled study to assess the treatment of hidradenitis suppurativa (HS) with a biologic drug shows that infliximab can safely improve disease severity, pain and quality of life. “We’re beginning to understand that HS is a closet disease. Many people have it, but it’s under-recognized, undertreated and difficult to manage,” says Francisco…

Read More

Botulinum Toxin Injections Demonstrate Anti-Depressive Effects in Recent Study

  New research suggests botulinum toxin type A has anti-depressive qualities along with its well-known cosmetic effects. Researchers from the University of Texas Southwestern, Austin, found that botulinum treatments injected between the eyebrows had an anti-depressive effect even after the treatment wore off and wrinkles returned. This suggests that the improvement in mood isn’t related…

Read More

Questions or want to talk to Dr. Tahernia?

Give us a call: (310) 614-9701
Request Appointment